← Eichor
Study identifier: NCT06202976 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mapping Epileptic Networks Using Multimodal Imaging

Condition: Epilepsy in Children  ·  Sponsor: Imagine Institute

PhaseN/A
Planned participants75
Who can joinAll sexes, N/A to 18 Years
Healthy volunteersNo

About this study

Currently, mapping the epileptogenic zone is based on a comprehensive preoperative assessment involving clinical, imaging and electrophysiological examinations. To reduce the need for invasive stereoelectroencephalography (SEEG) explorations, electrophysiological and imaging methods have been developed, such as resting-state functional MRI (fMRI) coupled with electroencephalogram and arterial spin-labeling perfusion MRI (ASL-MRI). It has been published that these new methods enable precise delineation of the epileptogenic zone and better preparation for surgery. The aim is to determine whether, in children with focal lesional epilepsy, the combination of ASL-MRI-EEG and resting-state fMRI-EEG enables precise identification of the epileptogenic zone to be defined by SEEG, the current reference examination.

This description comes directly from the study's public registry record.

Talk to the study team

Nathalie Boddaert, Pr  ·  +33 (0)1 44 49 51 75  ·  nathalie.boddaert@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Necker - Enfants Malades HospitalParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06202976